Drug Shortages reported to us

Drug Shortages can occur because of manufacturing and quality problems, delays and discontinuations.

Sort By: Date | Name

Thursday, September 4, 2025

FDA Azelastine Hydrochloride; Fluticasone Propionate Nasal Spray (NDC 00378345823) MYLAN

Wednesday, September 3, 2025

MFR Acyclovir 400 MG (NDC 31722077705) CAMBER PHARMACEUTICALS
MFR Buprenorphine HCl 8 MG (NDC 00054017713) HIKMA PHARMACEUTICALS USA

Wednesday, August 27, 2025

FDA Dobutamine Hydrochloride Injection (NDC 00409234488) HOSPIRA
FDA Dopamine Hydrochloride Injection (NDC 00409780924) HOSPIRA

Tuesday, August 19, 2025

FDA Finasteride Tablet (NDC 00093735556) TEVA PHARMACEUTICALS USA
FDA Finasteride Tablet (NDC 00093735505) TEVA PHARMACEUTICALS USA
FDA Finasteride Tablet (NDC 00093735598) TEVA PHARMACEUTICALS USA

Friday, August 15, 2025

FDA Celecoxib Capsule (NDC 00591398305) ACTAVIS PHARMA
FDA Celecoxib Capsule (NDC 00591398260) ACTAVIS PHARMA
FDA Celecoxib Capsule (NDC 00591398401) ACTAVIS PHARMA
FDA Celecoxib Capsule (NDC 00591398560) ACTAVIS PHARMA
FDA Celecoxib Capsule (NDC 00591398405) ACTAVIS PHARMA
FDA Celecoxib Capsule (NDC 00591398301) ACTAVIS PHARMA

Wednesday, August 13, 2025

FDA Palivizumab Injection (NDC 66658023001) SOBI
FDA Palivizumab Injection (NDC 66658023101) SOBI

Tuesday, August 12, 2025

FDA Desipramine Hydrochloride Tablet (NDC 23155058101) AVET PHARMACEUTICALS
FDA Desipramine Hydrochloride Tablet (NDC 23155057801) AVET PHARMACEUTICALS
FDA Desipramine Hydrochloride Tablet (NDC 23155058201) AVET PHARMACEUTICALS
FDA Desipramine Hydrochloride Tablet (NDC 23155058001) AVET PHARMACEUTICALS
FDA Desipramine Hydrochloride Tablet (NDC 23155057901) AVET PHARMACEUTICALS
FDA Desipramine Hydrochloride Tablet (NDC 23155058325) AVET PHARMACEUTICALS

Friday, August 8, 2025

FDA Amphotericin B Injection (NDC 57665010141) LEADIANT BIOSCIENCES

Monday, August 4, 2025

FDA Irinotecan Hydrochloride Injection (NDC 45963061451) ACTAVIS
FDA Irinotecan Hydrochloride Injection (NDC 45963061455) ACTAVIS

Friday, August 1, 2025

FDA Clindamycin Phosphate; Benzoyl Peroxide Gel (NDC 00591391668) ACTAVIS PHARMA

Tuesday, July 29, 2025

FDA Adefovir Dipivoxil Tablet (NDC 60505394703) APOTEX
FDA Esterified Estrogens Tablet (NDC 61570007301) PFIZER U.S.
FDA Esterified Estrogens Tablet (NDC 61570007550) PFIZER U.S.
FDA Esterified Estrogens Tablet (NDC 61570007401) PFIZER U.S.
FDA Esterified Estrogens Tablet (NDC 61570007201) PFIZER U.S.

Monday, July 28, 2025

FDA Voriconazole Tablet (NDC 00049317030) PFIZER U.S.

Thursday, July 24, 2025

FDA Glipizide Tablet Extended Release (NDC 00049017808) PFIZER U.S.

Wednesday, July 23, 2025

FDA Amantadine Hydrochloride Capsule (NDC 00832101550) UPSHER-SMITH
FDA Amantadine Hydrochloride Capsule (NDC 00832101500) UPSHER-SMITH
FDA Amantadine Hydrochloride Tablet (NDC 00832011103) UPSHER-SMITH
FDA Amantadine Hydrochloride Tablet (NDC 00832011150) UPSHER-SMITH
FDA Amantadine Hydrochloride Tablet (NDC 00832011100) UPSHER-SMITH
FDA Potassium Chloride Tablet Extended Release (NDC 00832532210) UPSHER-SMITH
FDA Potassium Chloride Tablet Extended Release (NDC 00245531515) UPSHER-SMITH
FDA Potassium Chloride Tablet Extended Release (NDC 00832532311) UPSHER-SMITH
FDA Potassium Chloride Tablet Extended Release (NDC 00245531611) UPSHER-SMITH
FDA Potassium Chloride Tablet Extended Release (NDC 00245531615) UPSHER-SMITH
FDA Potassium Chloride Tablet Extended Release (NDC 00245531511) UPSHER-SMITH
FDA Potassium Chloride Tablet Extended Release (NDC 00245531501) UPSHER-SMITH
FDA Potassium Chloride Tablet Extended Release (NDC 00832532211) UPSHER-SMITH
FDA Potassium Chloride Tablet Extended Release (NDC 00832532310) UPSHER-SMITH
FDA Potassium Chloride Tablet Extended Release (NDC 00245531601) UPSHER-SMITH

Monday, July 21, 2025

FDA Insulin Aspart Injection (NDC 73070010315) NOVO NORDISK PHARMA
FDA Insulin Aspart Injection (NDC 73070010215) NOVO NORDISK PHARMA
FDA Insulin Aspart Injection (NDC 73070010011) NOVO NORDISK PHARMA
FDA Insulin Aspart Protamine and Insulin Aspart Mix 70/30 Inject (NDC 73070020315) NOVO NORDISK PHARMA
FDA Insulin Aspart Protamine and Insulin Aspart Mix 70/30 Inject (NDC 73070020011) NOVO NORDISK PHARMA
FDA Insulin Degludec Injection (NDC 73070050315) NOVO NORDISK PHARMA
FDA Insulin Degludec Injection (NDC 73070040315) NOVO NORDISK PHARMA
FDA Insulin Degludec Injection (NDC 73070040011) NOVO NORDISK PHARMA

Thursday, July 17, 2025

FDA Lidocaine Patch (NDC 00591267930) NOVAPLUS/ACTAVIS
FDA Oxaprozin Tablet (NDC 00025138131) PFIZER U.S.
FDA Pemetrexed Ditromethamine Injection (NDC 00409106001) HOSPIRA
FDA Pemetrexed Ditromethamine Injection (NDC 00409106101) HOSPIRA
FDA Potassium Citrate Tablet Extended Release (NDC 00591268201) ACTAVIS PHARMA
FDA Potassium Citrate Tablet Extended Release (NDC 00591272901) ACTAVIS PHARMA
FDA Potassium Citrate Tablet Extended Release (NDC 00591274201) ACTAVIS PHARMA

Wednesday, July 16, 2025

FDA Ethionamide Tablet (NDC 00008411701) PFIZER U.S.

Thursday, July 10, 2025

FDA Levothyroxine Sodium Tablet (NDC 72305002530) PROVELL PHARMACEUTICALS
FDA Levothyroxine Sodium Tablet (NDC 72305002590) PROVELL PHARMACEUTICALS
FDA Levothyroxine Sodium Tablet (NDC 72305005030) PROVELL PHARMACEUTICALS
FDA Levothyroxine Sodium Tablet (NDC 72305005090) PROVELL PHARMACEUTICALS
FDA Levothyroxine Sodium Tablet (NDC 72305007530) PROVELL PHARMACEUTICALS
FDA Levothyroxine Sodium Tablet (NDC 72305007590) PROVELL PHARMACEUTICALS
FDA Levothyroxine Sodium Tablet (NDC 72305008830) PROVELL PHARMACEUTICALS
FDA Levothyroxine Sodium Tablet (NDC 72305008890) PROVELL PHARMACEUTICALS
FDA Levothyroxine Sodium Tablet (NDC 72305010030) PROVELL PHARMACEUTICALS
FDA Levothyroxine Sodium Tablet (NDC 72305010090) PROVELL PHARMACEUTICALS
FDA Levothyroxine Sodium Tablet (NDC 72305011230) PROVELL PHARMACEUTICALS
FDA Levothyroxine Sodium Tablet (NDC 72305011290) PROVELL PHARMACEUTICALS
FDA Levothyroxine Sodium Tablet (NDC 72305012530) PROVELL PHARMACEUTICALS
FDA Levothyroxine Sodium Tablet (NDC 72305012590) PROVELL PHARMACEUTICALS
FDA Levothyroxine Sodium Tablet (NDC 72305013730) PROVELL PHARMACEUTICALS
FDA Levothyroxine Sodium Tablet (NDC 72305013790) PROVELL PHARMACEUTICALS
FDA Levothyroxine Sodium Tablet (NDC 72305015030) PROVELL PHARMACEUTICALS
FDA Levothyroxine Sodium Tablet (NDC 72305015090) PROVELL PHARMACEUTICALS
FDA Levothyroxine Sodium Tablet (NDC 72305017530) PROVELL PHARMACEUTICALS
FDA Levothyroxine Sodium Tablet (NDC 72305017590) PROVELL PHARMACEUTICALS
FDA Levothyroxine Sodium Tablet (NDC 72305020030) PROVELL PHARMACEUTICALS
FDA Levothyroxine Sodium Tablet (NDC 72305020090) PROVELL PHARMACEUTICALS

Tuesday, July 8, 2025

FDA Morphine Sulfate Injection (NDC 00409189123) HOSPIRA
FDA Morphine Sulfate Injection (NDC 00409189201) HOSPIRA
FDA Morphine Sulfate Injection (NDC 00409189301) HOSPIRA
FDA Oseltamivir Phosphate Capsule (NDC 00004080285) GENENTECH

Important: Items shown in shortage are based on information provided by wholesalers when they list manufacturer out and discontinued items. Items are shown for 60 days from date of initial insertion on this list.